Sugar, ethanol, co-gen and nutraceuticals producer with Parry-branded consumer foods; Murugappa Group company.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 733 | −3.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -7.0 | −2.9 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -89.0 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. | |
| Return on equity | 9.72 | −0.0 pts | Trailing twelve months | TTM to Jun 2026 | Adjusted profit attributable to owners ÷ average owners’ equity. |
| Free cash flow margin | 0.02 | −4.2 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | 15.65 | +14.4 pts | Trailing twelve months | TTM to Jun 2026 | Revenue change against the same period one year earlier. |
Guidance
4 of 9 judged targets kept · 9 open · verdicts reflect calls analysed to Q1 FY27.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| PSRIPL Loan Obligations Completion | Complete all loan obligations by June 30, 2026 | Q4 FY26 | Management confirmed that ₹610 crores were infused 'to settle all the bank obligations, which has been closed.' | Achieved |
| Branded Packaged Food Growth | >12% Annual Growth | Q4 FY25 | Reported a 50% YoY degrowth in CPG turnover (₹94 crores). The original promise is obsolete due to the new strategy, but remains severely missed. | Missed |
| CPG Segment Break-even | Break even within the next 6-8 quarters | Q4 FY26 | Management revised the timeline, stating: 'we are working towards another 4 or 5 quarters. We should have a quarterly breakeven on this business.' This slightly accelerates the original timeline. | Revised Up |
5 of EID Parry's 18 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 15 more targets are in the full ledger.
Claimed
Qualified
Price
1Y: ₹1,038.8 on 24 Oct 2025 → ₹620.7. High ₹1,089.8 (29 Oct 2025), low ₹620.7 (27 Oct 2026).
Overview
Based on the company's own presentations, annual report and earnings calls.
EID Parry runs six integrated sugar factories with attached co-generation power plants and a standalone distillery across Tamil Nadu, Andhra Pradesh and Karnataka, converting sugarcane into sugar, ethanol/ENA and surplus power sold to the grid. Its Consumer Products Group sells branded sugar, jaggery and other sweeteners to retail under the Parry brand, sourced through both loose-to-branded and modern trade channels. Through subsidiaries including Valensa International (US), the Nutraceuticals business cultivates and formulates algae-based ingredients such as Spirulina and Astaxanthin into health supplements and functional foods sold in over 40 countries. The company is part of the Murugappa Group and also holds a stake in Coromandel International.
Segments
close before → close after
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Guidance
4 of 9 judged targets kept · 9 open · verdicts reflect calls analysed to Q1 FY27.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| PSRIPL Loan Obligations Completion | Complete all loan obligations by June 30, 2026 | Q4 FY26 | Management confirmed that ₹610 crores were infused 'to settle all the bank obligations, which has been closed.' | Achieved |
| Branded Packaged Food Growth | >12% Annual Growth | Q4 FY25 | Reported a 50% YoY degrowth in CPG turnover (₹94 crores). The original promise is obsolete due to the new strategy, but remains severely missed. | Missed |
| CPG Segment Break-even | Break even within the next 6-8 quarters | Q4 FY26 | Management revised the timeline, stating: 'we are working towards another 4 or 5 quarters. We should have a quarterly breakeven on this business.' This slightly accelerates the original timeline. | Revised Up |
Claimed
Qualified
The full ledger
A free account opens 5 company ledgers a month. All 18 tracked commitments, with each call’s wording and source.
Call summaries
EID Parry Q1 FY27
EID Parry reported a mixed Q1 FY27, with strong revenue growth in the sugar segment and improved realizations in power, while the CPG and Distillery segments faced headwinds. The company is actively recalibrating its CPG business for profitability and strengthening its balance sheet through working capital efficiency and asset monetization. The closure of PSRIPL's bank liabilities was a significant financial event this quarter.
Read the full callEID Parry Q4 FY26
EID Parry reported a mixed Q4 FY26, with strong growth in sugar and Nutra revenues, but a significant decline in its CPG segment and increased losses from refinery operations. The company is strategically recalibrating its CPG business towards higher-margin sweeteners and is progressing with the closure of its refinery subsidiary. Management expressed confidence in the long-term strategy and ethanol blending prospects, while acknowledging challenges in the global and domestic sugar market.
Read the full callEID Parry Q3 FY26
EID Parry reported a mixed Q3 FY26, marked by significant debt reduction in its refinery business and strong growth in sugar crushing and production volumes. However, the Consumer Products Group experienced a substantial decline in turnover due to channel restructuring and lower commodity prices, leading to a ₹10 crore impairment. The sugar and distillery segments continue to face cost pressures from stagnant ethanol prices and subscale operations, while the refinery business showed improved profitability.
Read the full callEvery analysed call
Fundamentals
Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2021 to Mar 2026).
Financials
Net profit, year on year: −218% (quarter to jun 2026 against jun 2025).
| Line item | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 755 | 848 | 814 | 760 | 754 | 770 | 846 | 733 |
| Expenses | 796 | 882 | 725 | 791 | 803 | 811 | 774 | 781 |
| Operating profit | -41 | -34 | 88 | -31 | -50 | -41 | 72 | -48 |
| Operating margin | −5.0% | −4.0% | 11.0% | −4.1% | −7.0% | −5.0% | 8.0% | −7.0% |
| Other income | 116 | -62 | -214 | 44 | -148 | 27 | -306 | 0 |
| Interest | 16 | 14 | 19 | 22 | 17 | 14 | 20 | 22 |
| Depreciation | 44 | 45 | 45 | 45 | 45 | 46 | 45 | 40 |
| Profit before tax | 15 | -155 | -190 | -53 | -260 | -73 | -299 | -110 |
| Tax rate | −89.0% | −6.0% | 22.0% | −48.0% | 10.0% | −26.0% | 14.0% | −19.0% |
| Net profit | 28 | -146 | -232 | -28 | -286 | -54 | -340 | -89 |
| EPS (₹ per share) | 1.59 | -8.24 | -13.03 | -1.57 | -16.06 | -3.06 | -19.14 | -5.02 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 29,193 | 2,809 | 3,168 | 3,130 |
| Expenses | 26,434 | 2,680 | 3,204 | 3,179 |
| Operating profit | 2,760 | 128 | -37 | -50 |
| Other income | 31 | 180 | -139 | -383 |
| Interest | 221 | 43 | 69 | 73 |
| Depreciation | 305 | 147 | 175 | 181 |
| Profit before tax | 2,264 | 115 | -419 | -685 |
| Net profit | 1,624 | 106 | -429 | -708 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 2,742 | 2,864 | 2,902 | 2,522 | 8,628 | 1,855 |
| Borrowings | 147 | 547 | 1,074 | 1,246 | 2,666 | 1,371 |
| Other liabilities | 1,168 | 557 | 673 | 622 | 18,647 | 1,175 |
| Total liabilities | 4,075 | 3,986 | 4,667 | 4,407 | 29,958 | 4,418 |
| Fixed assets | 1,244 | 1,271 | 1,387 | 1,635 | 7,514 | 1,393 |
| Capital work in progress | 15 | 84 | 284 | 26 | 967 | 7 |
| Investments | 1,119 | 992 | 1,074 | 662 | 3,750 | 626 |
| Other assets | 1,698 | 1,639 | 1,922 | 2,085 | 17,728 | 2,393 |
| Total assets | 4,075 | 3,986 | 4,667 | 4,407 | 29,958 | 4,418 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | -37 | 439 | -367 | -78 | -72 | 9 |
| Cash from investing | 645 | 269 | 76 | -276 | 62 | 521 |
| Cash from financing | -605 | -690 | 269 | 346 | 113 | 57 |
| Net cash flow | 3 | 18 | -21 | -8 | 103 | 587 |
| Free cash flow | -152 | 287 | -511 | -477 | -238 | 13 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 36 | 21 | 26 | 31 | 33 | 22 |
| Inventory days | 252 | 207 | 185 | 222 | 177 | 198 |
| Days payable | 80 | 72 | 54 | 58 | 44 | 46 |
| Cash conversion cycle | 208 | 157 | 157 | 196 | 167 | 173 |
| Working capital days | 28 | 39 | 67 | 67 | 40 | -84 |
| Return on capital employed | 14.0% | 12.0% | 12.0% | 4.0% | 2.0% | 4.0% |
| Dividend payout | 0.0% | 69.0% | 86.0% | 66.0% | 0.0% | 0.0% |
The businesses behind the company’s reported revenue.
Nutrient and allied business contributes 76.4% of reported segment revenue.
Quarter ended 30 Jun 2026 · Consolidated
₹6,951.03 crore
₹1,250.76 crore
₹475.00 crore
₹254.82 crore
₹94.20 crore
₹61.08 crore
₹6.66 crore
| Business segment | Revenue · ₹ crore | Share |
|---|---|---|
| Nutrient and allied business | 6,951.03 | 76.4% |
| Crop protection | 1,250.76 | 13.8% |
| Sugar | 475.00 | 5.2% |
| Distillery | 254.82 | 2.8% |
| Consumer products | 94.20 | 1.0% |
| Nutraceuticals | 61.08 | 0.7% |
| Co-generation | 6.66 | <0.1% |
Share = segment revenue ÷ total segment revenue, before intersegment adjustments.
Intersegment transactions are between the company’s own businesses. Net segment revenue can differ from income-statement revenue because reporting definitions differ.
Source: FinEdge · Last checked 19 Sept 2026. Reported segment names are kept as supplied.
Sugar shrank from 23% to 5% of revenue over the last two years.
| Segment | Mar 2024 | Jun 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Nutrient and allied business | 60% | 61% | 62% | 72% | 73% | 74% | — | 76% | +9.5% |
| Crop protection | — | — | 10% | 8% | 9% | 10% | — | 14% | +72.6% |
| Sugar | 23% | 23% | 20% | 14% | 13% | 11% | — | 5% | -62.3% |
| Distillery | 4% | 4% | 4% | 3% | 2% | 3% | — | 3% | -13.7% |
| Consumer products | — | — | 3% | 2% | 1% | 1% | — | 1% | -50.9% |
| Nutraceuticals | 1% | 1% | 1% | <1% | 1% | 1% | — | 1% | +126.7% |
| Co-generation | 1% | <1% | 1% | <1% | <1% | <1% | — | <1% | -11.6% |
Share of reported segment revenue by quarter, consolidated basis, as filed. A quarter the company did not report is left blank, never carried forward.
See how segments are shifting across companies → Segment Shift
Ownership
Promoters hold 41.28% as of Sept 2026; institutions added 2.29 pts since Jun 2026.
since Jun 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
The same filing shows 1 holder trimming and 1 off the list — both are in the register beside this.
Named in the Sep 2026 filing
Every holder of EID Parry above SEBI's 1% disclosure line, and what changed since Jun 2026.
| Holder | Stake | Change |
|---|---|---|
| 38.24% | unchanged | |
| 9.13% | newly disclosed | |
| Mutual fund | 6.30% | +0.41 pp |
| 2.56% | unchanged | |
| 2.01% | −0.20 pp | |
| 1.27% | newly disclosed | |
| Mutual fund | 1.17% | unchanged |
| 0.26% | unchanged | |
| 0.25% | unchanged | |
| 0.23% | unchanged | |
| 0.23% | unchanged | |
| 0.20% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Filings to Sep 2026
0 new, 3 added, 4 trimmed, 0 sold out — net +4.50 L shares (+1.7%).
| Scheme | Holding | Last month | Held since |
|---|---|---|---|
| Parag Parikh Flexi Cap Fund PPFAS Mutual Fund | ₹748 Cr | +3.70 L | Jan '24 |
| SBI Smallcap Fund SBI Mutual Fund | ₹686 Cr | +0.87 L | Jan '24 |
| SBI Children's Fund - Investment Plan (Erstwhile known as SBI Magnum Children's Benefit Fund- IP) SBI Mutual Fund | ₹232 Cr | held | Jan '24 |
| SBI Contra Fund SBI Mutual Fund | ₹138 Cr | held | Jul '24 |
| Parag Parikh ELSS Tax Saver Fund PPFAS Mutual Fund | ₹24 Cr | held | Jan '24 |
| Nippon India Nifty Smallcap 250 Index Fund Nippon India Mutual Fund | ₹11 Cr | −0.04 L | Oct '20 |
| SBI Nifty Smallcap 250 Index Fund SBI Mutual Fund | ₹6 Cr | −0.02 L | Oct '22 |
| SBI Children's Fund - Savings Plan (Erstwhile known as SBI Magnum Children's Benefit Fund-Svg P) SBI Mutual Fund | ₹1 Cr | held | Jan '24 |
HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.
Mutual funds Sep 2026
3 added, 4 trimmed — net +4.50 L shares (+1.7%)
Shares held by these funds +31151%
Oct '23 2.69 cr shares Sep '26
Your own record
Free account: one company. Everything above stays public.
Write why you follow EID Parry and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Guides on how to read this kind of business and the numbers that matter.